Counterpoints: Which should be used first in symptomatic metastatic castration-resistant prostate cancer, docetaxel or radium? Radium-223 is the preferred therapy in bone-predominant symptomatic metastatic castration-resistant prostate cancer.

Journal Article (Journal Article)

Full Text

Link to Item

Duke Authors

Armstrong, Andrew John

Cited Authors

Li, J; Armstrong, AJ

Published Date

May 2015

Published In

Clinical Advances in Hematology & Oncology : H&O

Volume / Issue

13 / 5

Start / End Page

293 - 298

PubMed ID

26352773

International Standard Serial Number (ISSN)

1543-0790

Language

eng

Conference Location

United States